6 - 12 Hours After Last Dose: Withdrawal Begins Onset of initial symptoms can include: Anxiety Muscle aches Increased tearing Insomnia Runny nose Excessive sweating Frequent yawning 24 - 48 Hours After Last Dose: Peak of Early Withdrawal Intensification of early symptoms and possible appearance of additional symptoms, such as: Agitation Diarrhea Heart palpitations High blood pressure Fever 72 Hours After Last Dose: Peak of Acute Withdrawal Typically, symptoms reach their peak in intensity and discomfort and can include: Nausea and vomiting Abdominal cramping Dilated pupils Goosebumps Blurred vision Rapid heartbeat 1 Week After Last Dose: Symptoms Begin to Subside At this time there is typically a gradual reduction in the intensity of physical symptoms, while psychological symptoms may persist or become more pronounced, including: Anxiety Depression Irritability Cravings for opioids 1 - 2 Weeks After Last Dose: Decrease in Physical Symptoms Most physical symptoms significantly diminish, while ongoing psychological and emotional challenges and the potential for continued cravings remain

Furthermore, legal analysts emphasize a critical, often misunderstood distinction: returning a peptide to Category 1 compounding eligibility is absolutely not the equivalent of achieving FDA drug approval
By completing your purchase, you acknowledge that SLU-PP-332 is an investigational material not approved for general medical or therapeutic use by any regulatory authority
Returns must be sent within 7 days of receiving the order at the expense of the customer, and a $25 refund request fee will be charged, as well as a 15% restocking fee
Insert the needle at 90 (if adequate subcutaneous fat) or 45 (if lean) [10]
Seahorse Wave software was used to analyze the results